These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 3613404)
1. An evaluation of the development of experimental membranous nephropathy. Gabbai FB; Gushwa LC; Wilson CB; Blantz RC Kidney Int; 1987 Jun; 31(6):1267-78. PubMed ID: 3613404 [TBL] [Abstract][Full Text] [Related]
2. An evaluation of the role of complement depletion in experimental membranous nephropathy in the rat. Gabbai FB; Mundy CA; Wilson CB; Blantz RC Lab Invest; 1988 May; 58(5):539-48. PubMed ID: 3367636 [TBL] [Abstract][Full Text] [Related]
3. Role of angiotensin II in experimental membranous nephropathy. Gabbai FB; Wilson CB; Blantz RC Am J Physiol; 1988 Apr; 254(4 Pt 2):F500-6. PubMed ID: 2833120 [TBL] [Abstract][Full Text] [Related]
4. Acute effect of passive Heymann nephritis on renal blood flow and glomerular filtration rate in rat: the effect of infusion of F(ab')2 fraction of anti-FX1(A) antibody. Sekse I; Iversen BM; Matre R; Ofstad J Nephron; 1991; 59(1):110-5. PubMed ID: 1944723 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of glomerulotubular balance in the setting of heterogeneous glomerular injury. Preservation of a close functional linkage between individual nephrons and surrounding microvasculature. Ichikawa I; Hoyer JR; Seiler MW; Brenner BM J Clin Invest; 1982 Jan; 69(1):185-98. PubMed ID: 7054238 [TBL] [Abstract][Full Text] [Related]
6. Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals. Salant DJ; Darby C; Couser WG J Clin Invest; 1980 Jul; 66(1):71-81. PubMed ID: 7400310 [TBL] [Abstract][Full Text] [Related]
7. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis. Susani M; Schulze M; Exner M; Kerjaschki D Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779 [TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of C5b-9 reflects disease activity in passive Heymann nephritis. Pruchno CJ; Burns MW; Schulze M; Johnson RJ; Baker PJ; Couser WG Kidney Int; 1989 Jul; 36(1):65-71. PubMed ID: 2681928 [TBL] [Abstract][Full Text] [Related]
10. Leukotriene D4 is a mediator of proteinuria and glomerular hemodynamic abnormalities in passive Heymann nephritis. Katoh T; Lianos EA; Fukunaga M; Takahashi K; Badr KF J Clin Invest; 1993 Apr; 91(4):1507-15. PubMed ID: 8386188 [TBL] [Abstract][Full Text] [Related]
11. Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat. Schulze M; Baker PJ; Perkinson DT; Johnson RJ; Ochi RF; Stahl RA; Couser WG Kidney Int; 1989 Jan; 35(1):60-8. PubMed ID: 2651753 [TBL] [Abstract][Full Text] [Related]
12. Acute effect of passive Heymann nephritis on renal blood flow and glomerular filtration rate in the rat: role of the anaphylatoxin C5a and the alpha-adrenergic nervous system. Sekse I; Iversen BM; Daha MR; Ofstad J Nephron; 1992; 60(4):453-9. PubMed ID: 1316560 [TBL] [Abstract][Full Text] [Related]